Sector revisions Charles River Laboratories International, Inc.

Stocks

Real-time Estimate Cboe BZX Other stock markets 12:34:51 2026-06-18 pm EDT			5-day change	1st Jan Change
183.04 ^USD	+0.39%		-2.87%	-8.43%

07:28am	Rothschild & Co Redburn Adjusts Charles River Laboratories International PT to $241 From $230, Maintains Buy Rating	MT
Jun. 17	Charles River Laboratories Shares Rise After Morgan Stanley Upgrade	MT

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	4m. EPS revision	1y. EPS revision	Visibility	Nbr of analysts
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.				15
LONZA GROUP AG				23
REVOLUTION MEDICINES, INC.				21
IQVIA HOLDINGS INC.				19
BEONE MEDICINES AG				27
CELLTRION, INC.				24
ASCENDIS PHARMA A/S	-	-		18
MEDPACE HOLDINGS, INC.				12
EUROFINS SCIENTIFIC SE				14
IONIS PHARMACEUTICALS, INC.				23
ICON PUBLIC LIMITED COMPANY				16
TEMPUS AI, INC.				15
BIO-TECHNE CORPORATION				13
BLUEPRINT MEDICINES CORPORATION			-	-
ABIVAX				6
QIAGEN N.V.				14
ALKERMES PLC				16
KYMERA THERAPEUTICS, INC.				21
PRAXIS PRECISION MEDICINES, INC.				17
Average				17
Weighted average by Cap.				20